Paul R Stauffer1, Dario B Rodrigues2, Robert Goldstein3, Thinh Nguyen1,4, Yan Yu1, Shuying Wan1, Richard Woodward5, Michael Gibbs5, Ilya L Vasilchenko6, Alexey M Osintsev7, Voichita Bar-Ad1, Dennis B Leeper1, Wenyin Shi1, Kevin D Judy8, Mark D Hurwitz1. 1. Radiation Oncology Department, Thomas Jefferson University, Philadelphia, PA, USA. 2. Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA. 3. AMF Life Systems, Auburn Hills, MI, USA. 4. Biomedical Engineering Department, Drexel University, Philadelphia, PA, USA. 5. BrachyThermix LLC, Voorhees, NJ, USA. 6. Head and Neck Department, Kemerovo Regional Clinical Oncology Center, Kemerovo, Russia. 7. General Physics Department, Kemerovo State University, Novostrojka, Russia. 8. Neurosurgery Department, Thomas Jefferson University, Philadelphia, PA, USA.
Abstract
AIM: Hyperthermia (HT) has been shown to improve clinical response to radiation therapy (RT) for cancer. Synergism is dramatically enhanced if HT and RT are combined simultaneously, but appropriate technology to apply treatments together does not exist. This study investigates the feasibility of delivering HT with RT to a 5-10mm annular rim of at-risk tissue around a tumor resection cavity using a temporary thermobrachytherapy (TBT) balloon implant. METHODS: A balloon catheter was designed to deliver radiation from High Dose Rate (HDR) brachytherapy concurrent with HT delivered by filling the balloon with magnetic nanoparticles (MNP) and immersing it in a radiofrequency magnetic field. Temperature distributions in brain around the TBT balloon were simulated with temperature dependent brain blood perfusion using numerical modeling. A magnetic induction system was constructed and used to produce rapid heating (>0.2°C/s) of MNP-filled balloons in brain tissue-equivalent phantoms by absorbing 0.5 W/ml from a 5.7 kA/m field at 133 kHz. RESULTS: Simulated treatment plans demonstrate the ability to heat at-risk tissue around a brain tumor resection cavity between 40-48°C for 2-5cm diameter balloons. Experimental thermal dosimetry verifies the expected rapid and spherically symmetric heating of brain phantom around the MNP-filled balloon at a magnetic field strength that has proven safe in previous clinical studies. CONCLUSIONS: These preclinical results demonstrate the feasibility of using a TBT balloon to deliver heat simultaneously with HDR brachytherapy to tumor bed around a brain tumor resection cavity, with significantly improved uniformity of heating over previous multi-catheter interstitial approaches. Considered along with results of previous clinical thermobrachytherapy trials, this new capability is expected to improve both survival and quality of life in patients with glioblastoma multiforme.
AIM: Hyperthermia (HT) has been shown to improve clinical response to radiation therapy (RT) for cancer. Synergism is dramatically enhanced if HT and RT are combined simultaneously, but appropriate technology to apply treatments together does not exist. This study investigates the feasibility of delivering HT with RT to a 5-10mm annular rim of at-risk tissue around a tumor resection cavity using a temporary thermobrachytherapy (TBT) balloon implant. METHODS: A balloon catheter was designed to deliver radiation from High Dose Rate (HDR) brachytherapy concurrent with HT delivered by filling the balloon with magnetic nanoparticles (MNP) and immersing it in a radiofrequency magnetic field. Temperature distributions in brain around the TBT balloon were simulated with temperature dependent brain blood perfusion using numerical modeling. A magnetic induction system was constructed and used to produce rapid heating (>0.2°C/s) of MNP-filled balloons in brain tissue-equivalent phantoms by absorbing 0.5 W/ml from a 5.7 kA/m field at 133 kHz. RESULTS: Simulated treatment plans demonstrate the ability to heat at-risk tissue around a brain tumor resection cavity between 40-48°C for 2-5cm diameter balloons. Experimental thermal dosimetry verifies the expected rapid and spherically symmetric heating of brain phantom around the MNP-filled balloon at a magnetic field strength that has proven safe in previous clinical studies. CONCLUSIONS: These preclinical results demonstrate the feasibility of using a TBT balloon to deliver heat simultaneously with HDR brachytherapy to tumor bed around a brain tumor resection cavity, with significantly improved uniformity of heating over previous multi-catheter interstitial approaches. Considered along with results of previous clinical thermobrachytherapy trials, this new capability is expected to improve both survival and quality of life in patients with glioblastoma multiforme.
Entities:
Keywords:
Hyperthermia; Magnetic nanoparticles; cancer; nanoparticles; thermobrachytherapy; tumorbed therapy
Authors: Robert Ivkov; Sally J DeNardo; Wolfgang Daum; Allan R Foreman; Robert C Goldstein; Valentin S Nemkov; Gerald L DeNardo Journal: Clin Cancer Res Date: 2005-10-01 Impact factor: 12.531
Authors: Philipp Kickingereder; Christina Hamisch; Bogdana Suchorska; Norbert Galldiks; Veerle Visser-Vandewalle; Roland Goldbrunner; Martin Kocher; Harald Treuer; Juergen Voges; Maximilian I Ruge Journal: J Neurooncol Date: 2014-08-24 Impact factor: 4.130
Authors: B Stea; K Rossman; J Kittelson; A Shetter; A Hamilton; J R Cassady Journal: Int J Radiat Oncol Biol Phys Date: 1994-10-15 Impact factor: 7.038
Authors: D B Rodrigues; P J S Pereira; P Limão-Vieira; P R Stauffer; P F Maccarini Journal: Int J Heat Mass Transf Date: 2013-07-01 Impact factor: 5.584
Authors: Matthew J Ware; Martyna Krzykawska-Serda; Jason Chak-Shing Ho; Jared Newton; Sarah Suki; Justin Law; Lam Nguyen; Vazrik Keshishian; Maciej Serda; Kimberly Taylor; Steven A Curley; Stuart J Corr Journal: Sci Rep Date: 2017-03-13 Impact factor: 4.379
Authors: Alexey M Osintsev; Ilya L Vasilchenko; Dario B Rodrigues; Paul R Stauffer; Vladimir I Braginsky; Vitaliy V Rynk; Egor S Gromov; Alexander Yu Prosekov; Andrey D Kaprin; Andrey A Kostin Journal: IEEE Trans Magn Date: 2021-07-16 Impact factor: 1.848